Endocyte Inc (NASDAQ:ECYT)

14.45
Delayed Data
As of May 18
 +0.94 / +6.96%
Today’s Change
1.17
Today|||52-Week Range
14.86
+237.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues70.4M70.0K70.0K70.0K
 
 
 
 
 
Depreciation And Amortization857.1K886.7K919.8K922.7K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses59.1M41.0M43.9M36.4M
 
 
 
 
 
Research And Development37.5M26.2M27.5M23.7M
 
 
 
 
 
Total Operating Expenses59.9M41.9M44.8M37.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income10.4M-41.8M-44.7M-37.3M
 
 
 
 
 
Extraordinary Charge-5.4M-134.0K0.00-18.8M
 
 
 
 
Interest Expense On Debt1.2K0.000.000.00
 
 
Other Expenses-144.7K51.6K-28.5K12.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.5M-41.3M-43.9M-55.1M
 
 
 
 
 
Net Income5.5M-41.3M-43.9M-55.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.2M41.9M42.2M43.9M
 
 
 
 
 
Shares To Calculate EPS Diluted41.8M41.9M42.2M43.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.13-$0.98-$1.04-$1.25
 
 
 
 
 
EPS Diluted$0.13-$0.98-$1.04-$1.25